Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease – CNBC

Weightloss News
Unlike tirzepatide, semaglutide only targets GLP-1. Don’t miss these stories from CNBC PRO: Forget ‘FANG’ and ‘Magnificent 7,’ the new hot portfolio …